SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-21-016027
Filing Date
2021-07-02
Accepted
2021-07-02 16:00:43
Documents
11
Period of Report
2021-04-16
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm 8-K/A 40600
2 ex23-1.htm EX-23.1 4618
3 ex23-2.htm EX-23.2 4610
4 ex99-1.htm EX-99.1 126194
5 ex99-2.htm EX-99.2 80843
6 ex99-3.htm EX-99.3 208998
7 ex99-4.htm EX-99.4 190974
8 ex99-5.htm EX-99.5 286735
9 ex99-1_001.jpg GRAPHIC 212366
10 ex99-1_002.jpg GRAPHIC 117074
11 ex99-2_001.jpg GRAPHIC 206151
  Complete submission text file 0001493152-21-016027.txt   1682762
Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36268 | Film No.: 211069810
SIC: 2835 In Vitro & In Vivo Diagnostic Substances